We look for founders using advanced technology or unique market insight to attack high impact problems in the real world, across themes like human health, climate & sustainability, manufacturing and food & agriculture. Our investments include Full Harvest, Mammoth Biosciences, Misty Robotics, Renew Financial, Palantir and Assurex Health.
Not Interested In
Entertainment, adtech, retail/ecommerce.
VC @ Claremont Creek Ventures • Investor @palantir-technologies, @badgeville, @snappytv, @flipswap • Founder @orbit-commerce • Worked at @rre-ventures, @in-q-tel, @bina-technologies
ACME is a venture capital firm based in San Francisco, California investing in founders with disruptive business models that can capitalize on current platforms, as well as those founders that are building breakthrough technologies for emerging new platfor
Investing in Software (Web Marketplace Saas..) &b... London, United Kingdom
$30000000 (Later stage VC)
$1500000 (Seed Round)
Alpha JWC Ventures
London, United Kingdom
Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • Mobile
Alpha JWC Ventures is a venture capital firm based in Jakarta Indonesia. The firm invests in early to later stage startups in Southeast Asia with Indonesia+ focus, meaning it invests mostly in either Indonesian startups, Indonesian founders, startups in Indonesia, or regional startups wanting to expand to Indonesia. Alpha JWC's investment is sector agnostic, but the firm has established expertise in fintech and consumer sector.
Creative Ventures is a venture capital firm that specializes in startup investments. The firm is based in San Francisco, California and invests in the business product, industry, agriculture and healthcare sectors. It was founded in 2016.
Kapor Capital is a venture capital firm that focuses on investing in companies operating in the information technology, education, health, work, finance, mobile, justice, food, media and retail sectors. The firm was founded in 2009 and is based in Oakland, California.
I'm looking for prime movers that are developing auto-pilot for the intelligent enterprise particularly in network and software monitoring, HR, sales, and supply chain. In consumer: marketplaces and anything with high engagement
Dr. Brian Dixon serves as Venture Partner at Elm Street Ventures. He also serves as the Chief Executive Officer of BioRelix, Inc. Prior to joining BioRelix in October 2007, Dr. Dixon served as Vice President with Bayer HealthCare in West Haven Connecticut. In that position, he led a multi-disciplinary organization of up to 130 employees that delivered state-of-the-art expertise in oncology biomarker discovery, new lead discovery, research drug formulation, pharmacokinetics and drug metabolism to Bayer's global R&D business. In addition, he held leadership roles in R&D licensing initiatives, strategic alliances and cross divisional collaborations in translational medicine. From 1998 to 2001, Dr. Dixon directed Bayer drug discovery efforts in both the Osteoporosis and Oncology therapeutic areas. He serves as a Director of BioRelix, Inc. Dr. Dixon was an undergraduate at the University of Michigan. He received his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and completed post-doctoral training at Harvard University.
Investing in Software (Web Marketplace Saas..) &b... Salt Lake City (UT) ,..., U.K.
$300000000 (Series D)
$55000000 (Series C)
$11000000 (Series A)
$27000000 (Series B)
$11000000 (Series A)
$100000000 (Series B)
$30000000 (Series B)
$12000000 (Series A)
• Climax Foods:
$44017000000 (Later stage VC)
• Starburst Data:
$118000000 (Later stage VC)
• Fast (Application Software):
$102000000 (Later stage VC)
$75000000 (Later stage VC)
• Duo Security:
$70000000 (Later stage VC)
• Kano Computing:
$28000000 (Later stage VC)
$25000000 (Later stage VC)
• Built Technologies, Inc.:
$21000000 (Early stage VC)
$20000000 (Later stage VC)
$19000000 (Early stage VC)
$11000000 (Later stage VC)
• Scoop Technologies:
$10600000 (Early stage VC)
$10000000 (Early stage VC)
$8000000 (Early stage VC)
• Gremlin Inc:
$7500000 (Early stage VC)
$4200000 (Early stage VC)
$4000000 (Early stage VC)
• Pitch Software:
Salt Lake City (UT) - Boston (MA) - Seattle (WA) - New York (NY) - Los Angeles (CA) - Toronto (Ontario) - San Francisco (CA) - Europe, operating in the biotechnology, retail, clean technology, media - U.K., U.K.
Dr. Beth Seidenberg is a partner at Kleiner Perkins Caufield & Byers focused on life science investing. She works with entrepreneurs to develop companies with breakthrough technology for treating patients and improving health.
Since joining KPCB in 2005, Beth has incubated five companies and serves on the board of directors of 3-V Biosciences, Armo Biosciences, Atara, Auxogyn, Breathe Technologies, Epizyme, iPierian, Redbrick Health and TESARO.
Before joining KPCB, Beth was senior vice president of development and chief medical officer of Amgen, Inc.
Earlier in her career, she was a senior executive in research and development at Bristol-Myers Squibb Co. and Merck & Co., Inc. Under her leadership, 10 innovative products were developed and marketed globally and achieved more than 40 regulatory approvals.
Beth received her B.S. degree from Barnard College and her M.D. from the University of Miami. She completed her post-graduate training at Johns Hopkins University, George Washington University and the National Institutes of Health.
London - Greenwich Connecticut - St Louis Missouri - Boston Massachusetts - Massachusetts - Efferson City Missouri - Salt Lake City, Utah - Saint Louis, Missouri, U.S.A.
Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Analytics • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness)
Founding Partner, Narrow Gauge Ventures
Southfield Capital Advisors is an operationally driven private investment firm focused on buying and building premier lower middle-market businesses in partnership with management. Founded in 2005 as the successor company to the private investment firm Levison & Company, Southfield Capital Advisors provides capital for majority recapitalizations and management-led buyouts of privately owned businesses. With $150 million of committed capital, Southfield makes investments in North American companies generating $5-15 million in EBITDA with proven business models, attractive growth and profitability trends, and solid leadership. The firm targets transactions in companies with $25-125 million in enterprise value, making investments of $10-40 million of equity. Industries of interest include: Business Services, Consumer Products & Services, Distribution & Fulfillment, Energy, Healthcare, Media & Entertainment, Niche Manufacturing, Power & Infrastructure, Specialty Finance, and Specialty Retail. The firm has additional offices in Greenwich, CT and Washington, DC.
Mohit Saxena is a Co-Founder at InMobi. He was the Chief Technology Officer at InMobi. Prior to joining InMobi, Mohit was based out of San Francisco and managed the technology operations at Virgin Mobile, world's largest mobile virtual network operator (MVNO). At Virgin Mobile, he was instrumental in designing and deploying post-paid billing system and revenue recognition system on a pre-paid platform. He also served as a Member at Mumbai Angel Venture Mentors. This helped significantly to make Virgin Mobile the largest and the most successful MVNO in the US. Mohit has also worked at AT&T and is a part of several patents filed in the telecommunication area. Mohit completed his undergraduate studies from the Indian Institute of Technology, Roorkee (IIT). He has an eye towards innovation and simplicity and is passionate about technology and its possibilities. Mohit was always fascinated by tales of people with small ideas turning them into global powerhouses and always dreamed of being the part of such an endeavor himself. So when opportunity knocked at his door to be the Technology Founder of InMobi, he jumped at it. It is Mohit's belief that strong discipline and desire to be at the top of the world will one day make InMobi one of the biggest and the smartest companies. He is also an Individual Member of Mumbai Angels.
Danielle Strachman is a Co-Founder and serves as the General Partner at 1517. In 2010, during the founding of the Thiel Fellowship, Danielle joined to lead the design and operations. She is the visionary behind the Thiel Summit series that has been attended by some 2000 young entrepreneurs. Previous to her work with Peter Thiel, Danielle founded and directed Innovations Academy in San Diego, a K-8 charter school serving 350 students, with a focus on student- led project based learning and other alternative progra
Washington Research Foundation (WRF) was founded in 1981 to help Washington State research institutions capture value from emerging technologies through intellectual property management and start-up investment activities. WRF is an independent private foundation whose operational revenue comes from retained funds from licensing and investing activities. WRF Capital manages Washington Research Foundation's (WRF) seed venture fund by creating and investing primarily in technology-based start-up companies that have strong ties to the University of Washington and other non-profit research institutions in Washington State. WRF Capital invests in two types of companies: (1) WRF founded companies in which WRF Capital and an entrepreneur create a business concept and start a company and (2) Non-WRF founded companies in which WRF Capital invests in a company opportunity presented by an entrepreneur. In both cases, WRF Capital actively seeks co-investors, investing up to $2 million in the firm's portfolio companies with proceeds from investments used to make financial gifts to Washington State research institutions. WRF invests only in companies located in Washington State with ties to not-for-profit research insitutions. The industry focus includes IT, Life Sciences, and Physical Sciences. In addition to providing seed capital through WRF Capital, the WRF leases office space to technology-based start-ups through the WRF Venture Center. The WRF Venture Center offers entrepreneurs short-term, flexible office facilities and business support in a desirable location on Lake Union, midway between the University District and downtown Seattle.
Renata Cooper serves as Board Member at iVvy. Renata Cooper is the Founder of Forming Circles Global and also serves as its Chief Executive Officer. She also serves as the Board Member of iVvy. She is a visionary entrepreneur and angel investor creating opportunities for market disruptors. She is one of Australia's foremost female angel investors helping transform innovative ideas into business realities. She is a member of Scale Investors, muru-D mentor, and a regular industry commentator for leading media titles. Through her investment portfolio, Renata is also a non-executive director of iVvy. Since 2011 when she launched Forming Circles as a social and ethical investment company, Renata has invested in over 100 businesses, individuals and organizations.
Investing in Software (Web Marketplace Saas..) &b... Bangalore Karnataka I..., India
• Fairassets Technologies:
• Wellthy Therapeutics:
Bangalore Karnataka India, India
Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • Material Science • Medical Devices (& Hospital Services)
Dr. Ranjan Pai is a Co-Founder & serves as Partner at Aarin Capital. He also serves as Advisor at Zodius Capital. At MEMG, Ranjan conceptualized the transformation of Manipal Hospitals into one of India's leading for-profit, multi-specialty healthcare chains in India. He also incubated Manipal Global Education Services and grew it to create one of India's largest education businesses. An active and successful investor in start-ups, Ranjan set up an investment fund jointly with former Infosys CFO, Mohandas Pai, to actively engage with dynamic entrepreneurs in life sciences, health care and skills augmentation. Dr. Ranjan Pai serves as a Managing Director, Board Member & Co-Chief Executive Officer at Manipal Global Education Services. He is the CEO of Manipal Education and Medical Group (MEMG) since 2005, the corporate holding entity of the group that focuses on Education, Healthcare and Research. With a keen understanding of the global business environment & a vision to place the Manipal Group on the global forefront in the space of education & healthcare, Dr. Ranjan Pai has been instrumental in restructuring the family run group & corporatizing it. Taking forward the Group's 60 year legacy, he has spearheaded & scaled the various business entities of the group to impressive heights both in India & abroad. He incubated Manipal Global Education Services, a leading global education and education services company headquartered in Bangalore, India. Ranjan conceptualized the transformation of Manipal Hospitals into a leading for-profit multi-specialty healthcare chain in India. He set up Stempeutics to undertake cutting-edge research in stem cell therapies. He also founded Manipal Infrastructure Services with the vision of creating India's premier student accommodation and facilities Services Company. Ranjan has a proven track record of successfully raising funding at different stages for MEMG Group Companies from marquee strategic and financial investors and delivering above market returns to his investors. Ranjan has incubated or has been an active financial investor in several start-ups. His investment track record includes several exceptional exits. He co-founded Aarin Capital to realize his ambition to actively engage with new ideas and dynamic entrepreneurs in life sciences, health care and training/skill augmentation. Ranjan graduated from Manipal University, Manipal and proceeded to study Hospital Administration in the United States. He also served as Board Member at Unitus Labs. He is also an Angel Investor.
Dr. Naeve joined Amgen in 2005 as a Director in the Company's corporate venture capital fund. She directs the fund's investment in early-stage biotechnology companies focused on discovering and developing human therapeutics.
From 2002 to 2005, Dr. Naeve was director of Corporate Development at X-Ceptor Therapeutics which was acquired by Exelixis.
Prior to this she was director of Business Development at Aurora Biosciences where she led transactions for the ion channel technology business unit and managed the collaborations with Pfizer, Merck, Lilly and Bristol Myers-Squibb.
Dr. Naeve holds a Ph.D. in Pathology from University of Southern California and completed a post-doctoral fellowship at the California Institute of Technology.
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Businesses Solutions • Energy • CleanTech • HealthTech (& Fitness) • Healthcare (& Wellness) • Mobile
Pravin Agarwala is a Co-Founder and serves as the Chief Executive Officer at BetterPlace. He also is an Angel Investor. Pravin is an IT industry veteran, a globally acknowledged Technology leader, an Entrepreneur and a dreamer. He headed the cloud based computing division for SAP as its Vice President for several years. He is currently the Advisor and Director for several technology led start-ups. He has a BE degree in Electronics and Telecommunications from Gauhati University in 1995.